Compile Data Set for Download or QSAR
Report error Found 54 Enz. Inhib. hit(s) with all data for entry = 50018430
TargetP2Y purinoceptor 6(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608213(CHEMBL5274126)
Affinity DataEC50:  1nMAssay Description:Agonist activity at P2Y6R in mouse adipose tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetP2Y purinoceptor 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50409523(CHEMBL2112093)
Affinity DataEC50:  0.400nMAssay Description:Agonist activity at human P2Y1R in human 1321N1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetP2Y purinoceptor 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50118242([({[(2R,3S,4R,5R)-5-[6-amino-2-(methylsulfanyl)-9H...)
Affinity DataEC50:  6.40nMAssay Description:Agonist activity at human P2Y1R in human 1321N1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetP2Y purinoceptor 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608212(CHEMBL5283886)
Affinity DataEC50:  8.40nMAssay Description:Agonist activity at human P2Y1R in human 1321N1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetP2Y purinoceptor 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608211(CHEMBL5276113)
Affinity DataEC50:  1.89E+4nMAssay Description:Agonist activity at human P2Y1R in human 1321N1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetP2Y purinoceptor 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608210(CHEMBL5269533)
Affinity DataEC50:  155nMAssay Description:Agonist activity at human P2Y1R in human 1321N1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetP2Y purinoceptor 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608209(CHEMBL1230817)
Affinity DataEC50:  1.28E+3nMAssay Description:Agonist activity at human P2Y1R in human 1321N1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetEquilibrative nucleoside transporter 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM23617(NBTI | Nitrobenzylthioinosine | CHEMBL418509 | (2R...)
Affinity DataIC50: 1nMAssay Description:Inhibition of ENT1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetEquilibrative nucleoside transporter 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608216(CHEMBL5277962)
Affinity DataIC50: 30nMAssay Description:Inhibition of ENT1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetSodium/nucleoside cotransporter 2(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608215(CHEMBL5270911)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CNT2More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetSodium/nucleoside cotransporter 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM23617(NBTI | Nitrobenzylthioinosine | CHEMBL418509 | (2R...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CNT1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetSodium/nucleoside cotransporter 2(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM23617(NBTI | Nitrobenzylthioinosine | CHEMBL418509 | (2R...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CNT2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetSodium/nucleoside cotransporter 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608215(CHEMBL5270911)
Affinity DataIC50: 4.90E+4nMAssay Description:Inhibition of human CNT1More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetSodium/nucleoside cotransporter 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608214(CHEMBL5285935)
Affinity DataIC50: 5.70E+4nMAssay Description:Inhibition of human CNT1More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetSodium/nucleoside cotransporter 2(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608214(CHEMBL5285935)
Affinity DataIC50: 1.45E+5nMAssay Description:Inhibition of human CNT2More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetEquilibrative nucleoside transporter 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608214(CHEMBL5285935)
Affinity DataIC50: 6.26E+5nMAssay Description:Inhibition of human recombinant ENT1 assessed as inhibition of [3H] uridine transportMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetEquilibrative nucleoside transporter 1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608215(CHEMBL5270911)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of human recombinant ENT1 assessed as inhibition of [3H] uridine transportMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A1(Bovine)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50224770((2R,3R,4R,5R)-2-(2-chloro-6-(cyclopentylamino)-9H-...)
Affinity DataKi:  1.80nMAssay Description:Binding affinity to bovine adenosine A1 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608217(CHEMBL5286886)
Affinity DataKi:  11nMAssay Description:Binding affinity to 5HT2B receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608219(CHEMBL5288004)
Affinity DataKi:  15nMAssay Description:Binding affinity to 5HT2B receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608218(CHEMBL5271021)
Affinity DataKi:  23nMAssay Description:Binding affinity to 5HT2B receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608219(CHEMBL5288004)
Affinity DataKi:  30nMAssay Description:Binding affinity to 5HT2C receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetKappa-type opioid receptor(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608206(CHEMBL5201437)
Affinity DataKi:  42nMAssay Description:Binding affinity to KOR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608217(CHEMBL5286886)
Affinity DataKi:  84nMAssay Description:Binding affinity to 5HT2C receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetEndoplasmin(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM21220(CHEMBL464859 | N-Ethylcarboxamidoadenosine | Adeno...)
Affinity DataKi:  110nMAssay Description:Inhibition of Grp94 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetKappa-type opioid receptor(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50603613(CHEMBL5169644)
Affinity DataKi:  207nMAssay Description:Binding affinity to KOR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608218(CHEMBL5271021)
Affinity DataKi:  269nMAssay Description:Binding affinity to 5HT2C receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608205(CHEMBL5274986)
Affinity DataKi:  404nMAssay Description:Binding affinity to human adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608206(CHEMBL5201437)
Affinity DataKi:  448nMAssay Description:Binding affinity to human adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50603613(CHEMBL5169644)
Affinity DataKi:  483nMAssay Description:Binding affinity to human adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetDelta-type opioid receptor(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50603613(CHEMBL5169644)
Affinity DataKi:  627nMAssay Description:Binding affinity to DOR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetMu-type opioid receptor(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608206(CHEMBL5201437)
Affinity DataKi:  637nMAssay Description:Binding affinity to MOR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetDelta-type opioid receptor(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608206(CHEMBL5201437)
Affinity DataKi:  786nMAssay Description:Binding affinity to DOR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A1(Rat)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608205(CHEMBL5274986)
Affinity DataKi:  1.68E+3nMAssay Description:Binding affinity to rat adenosine A1 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM21221(2-Cl-IB-MECA | CHEMBL431733 | C-IBzA-MU | 2-chloro...)
Affinity DataKi:  2.77E+3nMAssay Description:Binding affinity to 5HT2B receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Rat)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50224770((2R,3R,4R,5R)-2-(2-chloro-6-(cyclopentylamino)-9H-...)
Affinity DataKi:  5.00E+3nMAssay Description:Binding affinity to rat adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608207(CHEMBL5182934)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to mouse adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetMu-type opioid receptor(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50603613(CHEMBL5169644)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to MOR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM21221(2-Cl-IB-MECA | CHEMBL431733 | C-IBzA-MU | 2-chloro...)
Affinity DataKi:  1.00E+4nMAssay Description:Binding affinity to 5HT2C receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608219(CHEMBL5288004)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to 5HT2A receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608218(CHEMBL5271021)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to 5HT2A receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608217(CHEMBL5286886)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to 5HT2A receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM21221(2-Cl-IB-MECA | CHEMBL431733 | C-IBzA-MU | 2-chloro...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to 5HT2A receptor (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50116882(CHEMBL3612932)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to human adenosine A1 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A1(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50561600(CHEMBL4788488)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to human adenosine A1 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608206(CHEMBL5201437)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to mouse adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50603613(CHEMBL5169644)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to mouse adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A3(Mouse)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608208(CHEMBL5281049)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to mouse adenosine A3 receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A2a(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608205(CHEMBL5274986)
Affinity DataKi:  2.25E+4nMAssay Description:Binding affinity to human adenosine A2A receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
TargetAdenosine receptor A2b(Human)
National Institute of Diabetes & Digestive & Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50608205(CHEMBL5274986)
Affinity DataKi: >5.00E+4nMAssay Description:Binding affinity to human adenosine A2B receptor assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/19/2024
Entry Details
PubMed
Displayed 1 to 50 (of 54 total ) | Next | Last >>
Jump to: